⚕ GalenOps CRO console
← 701 (USA)

701-1111

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2012-09-07
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-13 (study day 7.0); relationship: NONE

moderate assessed 2026-08-18

Moderate CELLULITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-13 (study day 7.0); relationship: NONE

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

moderate assessed 2026-08-18

Moderate LOCALISED INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-07-08 (study day -61.0); relationship: NONE

mild assessed 2026-08-18

Mild MICTURITION URGENCY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-07 (study day 1.0); relationship: NONE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

mild assessed 2026-08-18

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.